Contact Us
  • Events News
1 min read

Deeptech Connect 2025

AcesoTherapeutics will be attending Deeptech Connect on November 4, 2025 – the flagship event organized by the #SATT network, showcasing the best of French #Deeptech startups. 🎯 A great opportunity to discover an investment opportunity in our novel cystic

AcesoTherapeutics will be attending Deeptech Connect on November 4, 2025 – the flagship event organized by the #SATT network, showcasing the best of French #Deeptech startups.

🎯 A great opportunity to discover an investment opportunity in our novel cystic fibrosis drug program, currently entering the preclinical (IND-enabling) stage.

🔗 for more information : 📍 Deeptech Connect – CENTQUATRE-PARIS ➕ www.deeptechconnect.fr

  • Article details

Category

Events News

Published

November 2, 2025

Reading time

1 min read

Topic

  • Share article
  • Explore more from ACESO

Uncategorized

Research news

Recognition

Publication

Press Release

Keep reading

Related news & insights

  • Events News

San Diego convention Center: June 22 – 25 – 2026

We are preparing to raise funds, with part already secured, to complete our regulatory preclinical studies, with CTA submission targeted for late 2027.
Read More
  • Company News

SATT AxLR enters the capital of Aceso Therapeutics and supports the development of ACT-101 for cystic fibrosis

Montpellier, March 2026 — Aceso Therapeutics announces the entry of SATT AxLR into its capital, marking a new milestone in the development of its biotech focused on innovative therapies for
Read More
  • Publication

European Young Investigators Meeting (EYIM) – March 2026

European Young Investigators Meeting (EYIM) - 2026
Read More
Back to all news

Get in touch

Partner with us to redefine cystic fibrosis care.

Whether you’re an investor, strategic partner, or member of the scientific community — we’d be glad to talk.

Request Information
Investor Relations

Email

contact@aceso-therapeutics.com

Headquarters

Montpellier, France